Skip to main content

Correction to: A multicentre, multi-national, double-blind, randomised, active-controlled, parallel-group clinical study to assess the safety and efficacy of PDA10 (Epoetin-Alfa) vs. Eprex® in patients with anaemia of chronic renal failure

The Original Article was published on 25 November 2021

Correction to: BMC Nephrology 22, 391 (2021)

https://doi.org/10.1186/s12882-021-02601-w

Following publication of the original article [1], the authors would like to correct a spelling mistake in title and in the body of the text.

The word currently reads: Alpha

The word should read: Alfa

The title has been updated above and the original article [1] has been corrected.

Reference

  1. Lim et al. A multicentre, multi-national, double-blind, randomised, active-controlled, parallel-group clinical study to assess the safety and efficacy of PDA10 (Epoetin-Alfa) vs. Eprex® in patients with anaemia of chronic renal failure. BMC Nephrol. 2021;22:391. https://doi.org/10.1186/s12882-021-02601-w.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Soo Kun Lim.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lim, S.K., Goh, B.L., Visvanathan, R. et al. Correction to: A multicentre, multi-national, double-blind, randomised, active-controlled, parallel-group clinical study to assess the safety and efficacy of PDA10 (Epoetin-Alfa) vs. Eprex® in patients with anaemia of chronic renal failure. BMC Nephrol 23, 14 (2022). https://doi.org/10.1186/s12882-021-02651-0

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12882-021-02651-0